- Home
- SOGP vs POAI Comparison
SOGP vs POAI Comparison
Compare SOGP & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOGP
- POAI
- Stock Information
- Founded
- SOGP 2010
- POAI 2002
- Country
- SOGP Singapore
- POAI United States
- Employees
- SOGP 563
- POAI N/A
- Industry
- SOGP
- POAI Industrial Specialties
- Sector
- SOGP
- POAI Health Care
- Exchange
- SOGP NYSE
- POAI Nasdaq
- Market Cap
- SOGP 6.9M
- POAI 8.9M
- IPO Year
- SOGP 2020
- POAI N/A
- Fundamental
- Price
- SOGP $1.27
- POAI $1.07
- Analyst Decision
- SOGP
- POAI Hold
- Analyst Count
- SOGP 0
- POAI 1
- Target Price
- SOGP N/A
- POAI N/A
- AVG Volume (30 Days)
- SOGP 72.6K
- POAI 104.2K
- Earning Date
- SOGP 05-19-2025
- POAI 05-20-2025
- Dividend Yield
- SOGP N/A
- POAI N/A
- EPS Growth
- SOGP N/A
- POAI N/A
- EPS
- SOGP N/A
- POAI N/A
- Revenue
- SOGP $278,363,908.00
- POAI $1,623,817.00
- Revenue This Year
- SOGP $48.88
- POAI $486.27
- Revenue Next Year
- SOGP N/A
- POAI $65.50
- P/E Ratio
- SOGP N/A
- POAI N/A
- Revenue Growth
- SOGP N/A
- POAI N/A
- 52 Week Low
- SOGP $1.18
- POAI $0.55
- 52 Week High
- SOGP $2.75
- POAI $3.06
- Technical
- Relative Strength Index (RSI)
- SOGP 26.87
- POAI 48.41
- Support Level
- SOGP $1.18
- POAI $0.85
- Resistance Level
- SOGP $2.28
- POAI $1.23
- Average True Range (ATR)
- SOGP 0.15
- POAI 0.09
- MACD
- SOGP -0.09
- POAI 0.01
- Stochastic Oscillator
- SOGP 8.14
- POAI 57.29
About SOGP SOUND GROUP INC SPON ADS EA REP 200 ORD SHS(POST SPLIT)
Sound Group Inc is a world-wide audio-centric social and entertainment company. It Leverages broad product portfolio and in-house technologies, Sound Group caters to user interest in audio entertainment and social networking. Sound Group nurtures a globally diverse and inclusive team, drawing on talent from various countries and regions world-wide.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.